上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1321Please respect copyright.PENANA0ps6JJwnwR
1321Please respect copyright.PENANA9c216UJtwY
上集:https://www.penana.com/article/4711251321Please respect copyright.PENANA6TFPZvBZAU
1321Please respect copyright.PENANAltUfXllPjV1321Please respect copyright.PENANANoJJCtsTFL
1321Please respect copyright.PENANASvFK2qkbxf
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1321Please respect copyright.PENANAP0QKFqbljj
1321Please respect copyright.PENANAKTeHfVeSOp
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1321Please respect copyright.PENANAaHfgSJehUu
1321Please respect copyright.PENANAwYDNEuXlgU
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1321Please respect copyright.PENANABf6WTSxjTK
1321Please respect copyright.PENANA0Lvtn1Vqew1321Please respect copyright.PENANAbtp1dWaPd0
1321Please respect copyright.PENANAU9erJFr2vQ
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1321Please respect copyright.PENANA9FV5Qp0VNe
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1321Please respect copyright.PENANArD6yOZ77BS
1321Please respect copyright.PENANAbH6rCPhtgT
忘記甚麼是Neoantigen的話,可重溫上一集。1321Please respect copyright.PENANAxtbzIQftp3
1321Please respect copyright.PENANAQuJAbMzRPo
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1321Please respect copyright.PENANAKES683RzWT
1321Please respect copyright.PENANAjVtEpjXFch
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1321Please respect copyright.PENANAW9RW3yeG8e
1321Please respect copyright.PENANAvGNIb5uuWy1321Please respect copyright.PENANAU0ZJSNZzH2
1321Please respect copyright.PENANAi8RGWW5E6h
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1321Please respect copyright.PENANAUYiCqAObN8
1321Please respect copyright.PENANA0N1W5CUoJ2
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1321Please respect copyright.PENANA19obYmXenk
1321Please respect copyright.PENANA97fDN37Xyc
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1321Please respect copyright.PENANAwhDv30mi5W1321Please respect copyright.PENANAE3h21EBDoj
1321Please respect copyright.PENANAp6PgkAEBfY
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1321Please respect copyright.PENANAEiu6HDdJTW
1321Please respect copyright.PENANAehCBs4fDqr
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1321Please respect copyright.PENANAeiq30FRU0U1321Please respect copyright.PENANAQ435xBDQ4R
1321Please respect copyright.PENANAzMssHRak1h
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1321Please respect copyright.PENANAG5d9GZZ8XK
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1321Please respect copyright.PENANAZoD145DGPK
1321Please respect copyright.PENANAMjNICmI7M7
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1321Please respect copyright.PENANAdgo2GHNsrk
1321Please respect copyright.PENANAFHDxRhw495
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1321Please respect copyright.PENANA1OWssar6Tl
1321Please respect copyright.PENANAYHJ3LX6cWi
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1321Please respect copyright.PENANAg3QhGrNKmH
1321Please respect copyright.PENANAJxa5Gmzx5x
1321Please respect copyright.PENANA5Yy3IHtns5
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1321Please respect copyright.PENANA89dbhkyEmp
1321Please respect copyright.PENANANPS0m3EYx5
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1321Please respect copyright.PENANAqw7RcZzpTP
1321Please respect copyright.PENANAhoagFyKzVb
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1321Please respect copyright.PENANArvSUNgty47
1321Please respect copyright.PENANAJFJQe2dZtI
Link:1321Please respect copyright.PENANAegvI6qJQ4O
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1321Please respect copyright.PENANAu3uF694fnK
1321Please respect copyright.PENANAtdgnwe9pj9
1321Please respect copyright.PENANA4c5mpMDYcT
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1321Please respect copyright.PENANAEGJShhNWwh